https://www.ampulmonary.com/copd/article/22978362/phase-3-trial-initiated-for-investigational-oral-copd-therapyPulmonaryen2026-11-12T21:00:00.000ZPhase 3 trial initiated for investigational oral COPD therapyhttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/11/verducatib.tSHP5Q1u33.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/copd/article/22978360/merck-begins-phase-3-study-for-ensifentrine-copd-treatmentPulmonaryen2026-11-12T21:00:00.000ZMerck begins phase 3 study for ensifentrine COPD treatmenthttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/11/merck-trial.mlTrS8up5n.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/asthma/article/22978308/three-new-genes-linked-to-allergic-asthmaPulmonaryen2026-11-11T18:49:58.000ZThree new genes linked to allergic asthmahttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/11/gettyimages-487041749.5X8oDEzfLx.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/asthma/article/22978307/mental-health-comorbidity-worsens-asthma-outcomes-in-us-adultsPulmonaryen2026-11-11T18:44:19.000ZAsthma worsens alongside mental health conditionshttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/11/gettyimages-2282179599.vEeAX56Usm.jpg?auto=format%252Ccompress&q=70